PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments

NEXT STORY
Reliq Health Technologies, Inc. Files Q1 FY2022 Quarterly Financial Statements, Provides Corporate Update
PREV STORY
OSE Immunotherapeutics Provides an Update on the First Positive Results and Clinical Development of CoVepiT, its Multi-Target T-cell Anti-COVID Vaccine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Spero Therapeutics Receives FDA Fast Track Designation for SPR994 for the treatment of Complicated Urinary Tract infections and Acute Pyelonephritis

author_avatar
NASDAQ Market News

ePlus and Garrett Regional Medical Center Create Hospital without Walls

HERNDON, Va., Jan. 04, 2017 (GLOBE NEWSWIRE) -- ePlus inc. (NASDAQ:PLUS) today announced that ...

author_avatar
NASDAQ Market News

NextCure to Present at The JMP Securities Hematology and Oncology Summit

author_avatar
NASDAQ Market News